Nu Skin Enterprises, Inc.
NUS
$7.35
-$0.095-1.28%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -12.66% | -8.82% | -13.76% | -12.23% | -13.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -12.66% | -8.82% | -13.76% | -12.23% | -13.33% |
| Cost of Revenue | -4.64% | 80.96% | -37.69% | -2.68% | -7.74% |
| Gross Profit | -16.02% | -23.96% | 3.15% | -15.78% | -15.47% |
| SG&A Expenses | -16.67% | -12.26% | -11.11% | -12.05% | -13.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.97% | 4.30% | -21.56% | -9.28% | -11.91% |
| Operating Income | -4.67% | -65.57% | 169.15% | -44.02% | -38.28% |
| Income Before Tax | 12,125.34% | -719.66% | 138.60% | -454.72% | -92.45% |
| Income Tax Expenses | 1,557.65% | -1,160.46% | 99.52% | -231.00% | -49.13% |
| Earnings from Continuing Operations | 20,271.67% | -595.81% | 122.47% | -539.75% | -104.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20,271.67% | -595.81% | 122.47% | -539.75% | -104.69% |
| EBIT | -4.67% | -65.57% | 169.15% | -44.02% | -38.28% |
| EBITDA | -14.47% | -56.46% | 460.09% | -32.55% | -16.39% |
| EPS Basic | 20,104.63% | -592.74% | 122.53% | -541.89% | -104.71% |
| Normalized Basic EPS | 40.62% | -68.58% | 138.71% | -52.07% | -66.15% |
| EPS Diluted | 19,914.81% | -615.11% | 122.53% | -541.89% | -104.71% |
| Normalized Diluted EPS | 38.98% | -68.54% | 138.69% | -51.84% | -65.86% |
| Average Basic Shares Outstanding | 0.46% | 0.61% | -0.30% | -0.49% | -0.21% |
| Average Diluted Shares Outstanding | 1.59% | 0.47% | -0.25% | -0.94% | -1.04% |
| Dividend Per Share | 0.00% | -84.62% | -84.62% | -84.62% | -84.62% |
| Payout Ratio | 1.01% | -1.03% | 1.68% | -1.03% | -4.28% |